×
The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine PDF
$ 40.00
The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine PDF quantity
$ 40.00
×
Is Psychopharmacologic Treatment Associated With Neuropsychological Deficits in Bipolar Youth? PDF
$ 40.00
Is Psychopharmacologic Treatment Associated With Neuropsychological Deficits in Bipolar Youth? PDF quantity
$ 40.00
×
Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response: Reexploring the Adjunctive Ketamine Study of Taiwanese Patients With Treatment-Resistant Depression PDF
$ 40.00
Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response: Reexploring the Adjunctive Ketamine Study of Taiwanese Patients With Treatment-Resistant Depression PDF quantity
$ 40.00
×
QTc Prolongation in a Young Healthy Patient Receiving Citalopram 40 mg PDF
$ 40.00
QTc Prolongation in a Young Healthy Patient Receiving Citalopram 40 mg PDF quantity
$ 40.00
×
A Randomized, Double-Blind, Placebo-Controlled Study of Light Therapy for Antepartum Depression PDF
$ 40.00
A Randomized, Double-Blind, Placebo-Controlled Study of Light Therapy for Antepartum Depression PDF quantity
$ 40.00
×
Parry-Romberg Syndrome With Abnormal Cavum Septum Pellucidum Presenting as Obsessive-Compulsive Disorder PDF
$ 40.00
Parry-Romberg Syndrome With Abnormal Cavum Septum Pellucidum Presenting as Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Effects of Parental Opioid Use: Outcomes of Children of Parents in Medication-Assisted Treatment Compared to Healthy Controls PDF
$ 40.00
Effects of Parental Opioid Use: Outcomes of Children of Parents in Medication-Assisted Treatment Compared to Healthy Controls PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart